Distinguished in Plaque Psoriasis

Dr. Francisco Kerdel

Dermatology
Dermatology Group Of Florida PA
475 Biltmore Way Ste 207, 
Coral Gables, FL 

Distinguished in Plaque Psoriasis
Dermatology Group Of Florida PA
475 Biltmore Way Ste 207, 
Coral Gables, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Francisco Kerdel is a Dermatologist in Coral Gables, Florida. Dr. Kerdel is rated as a Distinguished provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Psoriasis, Plaque Psoriasis, Pyoderma Gangrenosum, and Hidradenitis Suppurativa.

His clinical research consists of co-authoring 76 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles and participated in 4 clinical trials in the study of Plaque Psoriasis.

Specialties
Dermatology
Licenses
Dermatology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 27 Less Insurance Carriers -

Locations

Dermatology Group of Florida PA
475 Biltmore Way Ste 207, Coral Gables, FL 33134
Call: 305-324-2110
Other Locations
Florida Academic Dermatology Centers LLC
1400 NW 12th Ave Ste 4, Miami, FL 33136
Call: 305-324-2110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 1
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: NKTR-358
Study Phase: Phase 1
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
Enrollment Status: Completed
Publish Date: September 25, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 9 Less Clinical Trials

76 Total Publications

An Open-Label, Single-Center Proof of Concept Study Evaluating the Efficacy and Safety of Tirzepatide for Moderate to Severe Hidradenitis Suppurativa.
An Open-Label, Single-Center Proof of Concept Study Evaluating the Efficacy and Safety of Tirzepatide for Moderate to Severe Hidradenitis Suppurativa.
Journal: Journal of drugs in dermatology : JDD
Published: December 02, 2025
View All 76 Publications
Similar Doctors
Distinguished in Plaque Psoriasis
Dr. Jordan Schwartzberg
Dermatology
Distinguished in Plaque Psoriasis
Dr. Jordan Schwartzberg
Dermatology

Office

9325 Glades Rd Ste 207, 
Boca Raton, FL 
 (40.9 miles away)
561-487-7575
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jordan Schwartzberg is a Dermatologist in Boca Raton, Florida. Dr. Schwartzberg is rated as a Distinguished provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Liver Spots, Universal Acquired Melanosis, Plaque Psoriasis, and Kaposiform Hemangioendothelioma.

Distinguished in Plaque Psoriasis
Dr. Brad Glick
Dermatology
Distinguished in Plaque Psoriasis
Dr. Brad Glick
Dermatology

Office

3275 N State Road 7, 
Margate, FL 
 (33.1 miles away)
954-974-3664
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Brad Glick is a Dermatologist in Margate, Florida. Dr. Glick is rated as a Distinguished provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Liver Spots, Universal Acquired Melanosis, Plaque Psoriasis, and Psoriasis.

Distinguished in Plaque Psoriasis
Dr. Jodi Fiedler
Dermatology
Distinguished in Plaque Psoriasis
Dr. Jodi Fiedler
Dermatology

Dermpartners Inc

21020 State Road 7 Ste 120, 
Boca Raton, FL 
 (38.8 miles away)
561-883-5640
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jodi Fiedler is a Dermatologist in Boca Raton, Florida. Dr. Fiedler is rated as a Distinguished provider by MediFind in the treatment of Plaque Psoriasis. Her top areas of expertise are Universal Acquired Melanosis, Liver Spots, Plaque Psoriasis, and Psoriasis.

VIEW MORE PLAQUE PSORIASIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kerdel's expertise for a condition
ConditionClose
    • Distinguished
    • Hidradenitis Suppurativa
      Dr. Kerdel is
      Distinguished
      . Learn about Hidradenitis Suppurativa.
      See more Hidradenitis Suppurativa experts
    • Plaque Psoriasis
      Dr. Kerdel is
      Distinguished
      . Learn about Plaque Psoriasis.
      See more Plaque Psoriasis experts
    • Psoriasis
      Dr. Kerdel is
      Distinguished
      . Learn about Psoriasis.
      See more Psoriasis experts
    • Pyoderma Gangrenosum
      Dr. Kerdel is
      Distinguished
      . Learn about Pyoderma Gangrenosum.
      See more Pyoderma Gangrenosum experts
    • Advanced
    • Actinic Keratosis
      Dr. Kerdel is
      Advanced
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Acute Febrile Neutrophilic Dermatosis
      Dr. Kerdel is
      Advanced
      . Learn about Acute Febrile Neutrophilic Dermatosis.
      See more Acute Febrile Neutrophilic Dermatosis experts
    • Alopecia Areata
      Dr. Kerdel is
      Advanced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Atopic Dermatitis
      Dr. Kerdel is
      Advanced
      . Learn about Atopic Dermatitis.
      See more Atopic Dermatitis experts
    • Autosomal Recessive Hypotrichosis
      Dr. Kerdel is
      Advanced
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Bullous Pemphigoid
      Dr. Kerdel is
      Advanced
      . Learn about Bullous Pemphigoid.
      See more Bullous Pemphigoid experts
    View All 27 Advanced Conditions
    • Experienced
    • Acrogeria, Gottron Type
      Dr. Kerdel is
      Experienced
      . Learn about Acrogeria, Gottron Type.
      See more Acrogeria, Gottron Type experts
    • Alopecia Totalis
      Dr. Kerdel is
      Experienced
      . Learn about Alopecia Totalis.
      See more Alopecia Totalis experts
    • Athlete's Foot
      Dr. Kerdel is
      Experienced
      . Learn about Athlete's Foot.
      See more Athlete's Foot experts
    • Autoerythrocyte Sensitivity
      Dr. Kerdel is
      Experienced
      . Learn about Autoerythrocyte Sensitivity.
      See more Autoerythrocyte Sensitivity experts
    • Basal Cell Skin Cancer
      Dr. Kerdel is
      Experienced
      . Learn about Basal Cell Skin Cancer.
      See more Basal Cell Skin Cancer experts
    • Bazex Syndrome
      Dr. Kerdel is
      Experienced
      . Learn about Bazex Syndrome.
      See more Bazex Syndrome experts
    View All 101 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.